Hartmann, L;Neveling, K;Borkens, S;Schneider, H;Freund, M;Grassman, E;Theiss, S;Wawer, A;Burdach, S;Auerbach, AD;Schindler, D;Hanenberg, H;Schaal, H.Correct mRNA processing at a mutant TT splice donor in FANCC ameliorates the clinical phenotype in patients and is enhanced by delivery of suppressor U1 snRNAs..Am J Hum Genet.2010.87.4.480-93

Warncke, K;Engelsberger, I.Diabetic Ketoacidosis in Children and Adolescents.DIABETES STOFFWECHSEL UND HERZ.2010.19.6.435-439

Keymeulen, B;Candon, S;Fafi-Kremer, S;Ziegler, A;Leruez-Ville, M;Mathieu, C;Vandemeulebroucke, E;Walter, M;Crenier, L;Thervet, E;Legendre, C;Pierard, D;Hale, G;Waldmann, H;Bach, JF;Seigneurin, JM;Pipeleers, D;Chatenoud, L.Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients..Blood.2010.115.6.1145-55

Achenbach, P;Krause, S;Ziegler, AG.Pathogenesis of type 1 diabetes mellitus - Update 2010.Dibaetol Stoffwechs.2010.5.3.R29-+

Adler, K;Henneberger, L;Huber, C;Falk, C;Ziegler, AG.Competence Network for diabetes mellitus bundles Germany-wide diabetes expertise..DIABETES STOFFWECHSEL UND HERZ.2010.19.5.360-+

Hale, G;Rebello, P;Al Bakir, I;Bolam, E;Wiczling, P;Jusko, WJ;Vandemeulebroucke, E;Keymeulen, B;Mathieu, C;Ziegler, AG;Chatenoud, L;Waldmann, H.Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in the treatment of type 1 diabetes..J Clin Pharmacol.2010.50.11.1238-48

Bonifacio, E;Yu, L;Williams, AK;Eisenbarth, GS;Bingley, PJ;Marcovina, SM;Adler, K;Ziegler, AG;Mueller, PW;Schatz, DA;Krischer, JP;Steffes, MW;Akolkar, B.Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia..J Clin Endocrinol Metab.2010.95.7.3360-7

Wenzlau, JM;Walter, M;Gardner, TJ;Frisch, LM;Yu, L;Eisenbarth, GS;Ziegler, AG;Davidson, HW;Hutton, JC.Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects..J Clin Endocrinol Metab.2010.95.10.4712-9

Ziegler, AG;Nepom, GT.Prediction and pathogenesis in type 1 diabetes..Immunity.2010.32.4.468-78

Bonifacio, E;Ziegler, AG.Advances in the prediction and natural history of type 1 diabetes..Endocrinol Metab Clin North Am.2010.39.3.513-25